Trientine Hydrochloride

二盐酸曲恩汀

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameTrientine Hydrochloride
Drug Alias Name苯甲二氮卓Trientine dihydrochloridetrientina盐酸曲恩汀三乙烯四胺 +[16
ClassificationSmall molecules
Mechanisms of ActionCopper chelating agents
TargetsCopper
Therapy Area/IndicationsHeart FailureCardiomyopathy, HypertrophicMacular Edema +[4
Global Approved IndicationsHepatolenticular Degeneration
Approved Indications in ChinaHepatolenticular Degeneration
Original Approved Country/TerritoryUnited States
Original Approved Date1985/11/08
Country/TerritoryCanadaUnited StatesGermany +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active IndicationsHeart FailureCardiomyopathy, HypertrophicHepatolenticular Degeneration
Inactive IndicationsMacular Edema

Other Information

ATC CodeA16AX12